CORZ — Core Scientific Income Statement

0.000.00%

Last trade - 00:00

FinancialsSpeculativeLarge CapNeutral

Annual income statement for Core Scientific, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	R2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	544	640	502	511	319
Cost of Revenue
Gross Profit	239	8.4	123	121	37.9
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	421	2,553	664	544	577
Operating Profit	123	-1,912	-162	-33.2	-258
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	63.1	-2,163	-246	-1,437	-288
Provision for Income Taxes
Net Income After Taxes	47.3	-2,146	-246	-1,438	-289
Net Income Before Extraordinary Items
Net Income	47.3	-2,146	-246	-1,438	-289
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	47.3	-2,146	-246	-1,245	-281
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.251	-3.09	-0.354	-4.8	-0.757